Soleus Capital Management, L.P. Tg Therapeutics, Inc. Call Options Transaction History
Soleus Capital Management, L.P.
- $1.21 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
412Shares Held
88MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$323 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$211 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$93.2 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY2.64MShares$75.1 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.13B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...